CNS activity of trastuzumab deruxtecan in HER2-expressing non-small-cell lung cancer

被引：0
|
作者：
Lazaratos, Anna-Maria [1 ]
Petrecca, Kevin [2 ]
Guiot, Marie-Christine [2 ]
Dankner, Matthew [1 ]
Jerzak, Katarzyna J. [3 ]
机构：
[1] McGill Univ, Rosalind & Morris Goodman Canc Res Inst, Montreal, PQ H3A 1A3, Canada
[2] McGill Univ, Montreal Neurol Inst Hosp, Montreal, PQ H3A 1A3, Canada
[3] Univ Toronto, Sunnybrook Odette Canc Ctr, Div Med Oncol, Toronto, ON, Canada
来源：
LANCET ONCOLOGY | 2024年 / 25卷 / 07期
关键词：
BRAIN METASTASES;
D O I：
10.1016/S1470-2045(24)00261-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e282 / e282
页数：1
相关论文
共 50 条
  • [31] A multicenter, multicohort, phase 2 study of trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing metastatic colorectal cancer - Trial in progress
    Yoshino, T.
    Siena, S.
    Dalal, R.
    Okuda, Y.
    Yamamoto, E.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] Trastuzumab Deruxtecan Monotherapy in Pretreated HER2-overexpressing Nonsquamous Non-Small Cell Lung Cancer: DESTINY-Lung03 Part 1
    Planchard, D.
    Kim, H. R.
    Suksombooncharoen, T.
    Li, R.
    Samol, J.
    Runglodvatana, Y.
    Lee, K. -Y.
    Chang, G. -C.
    Kowalski, D.
    Han, J. -Y.
    Saw, S.
    Huang, Y.
    Sookprasert, A.
    Nakajima, E.
    Alfon, J.
    Chang, Y. -T.
    Yang, J. C. -H.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S46 - S47
  • [33] A randomized, phase II, multicenter, open-label study of trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing gastric cancer
    Shitara, K.
    Bang, Y-J.
    Sakai, D.
    Yasui, H.
    Kawaguchi, Y.
    Sugihara, M.
    Saito, K.
    Dalal, R.
    Yamaguchi, K.
    ANNALS OF ONCOLOGY, 2018, 29 : 65 - 65
  • [34] Loss of Rb1 Associated With the Onset of Acquired Resistance to Trastuzumab Deruxtecan in TP53-/HER2-Mutated Non-Small-Cell Lung Cancer: Case Series
    Gupta, Ashish
    Jatwani, Karan
    Gupta, Kush
    Qiu, Jingxin
    Dy, Grace K.
    JCO PRECISION ONCOLOGY, 2023, 7
  • [35] Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
    Smit, Egbert F.
    Felip, Enriqueta
    Uprety, Dipesh
    Nagasaka, Misako
    Nakagawa, Kazuhiko
    Rodriguez, Luis Paz-Ares
    Pacheco, Jose M.
    Li, Bob T.
    Planchard, David
    Baik, Christina
    Goto, Yasushi
    Murakami, Haruyasu
    Saltos, Andreas
    Pereira, Kaline
    Taguchi, Ayumi
    Cheng, Yingkai
    Yan, Qi
    Feng, Wenqin
    Tsuchihashi, Zenta
    Janne, Pasi A.
    LANCET ONCOLOGY, 2024, 25 (04): : 439 - 454
  • [36] Population pharmacokinetics of trastuzumab deruxtecan (T-DXd) in subjects with HER2-mutant and HER2-overexpressing non-small cell lung cancer (NSCLC)
    Khatri, Amit
    Cobbina, Enoch
    Cheng, Shen
    Abutarif, Malaz
    Garimella, Tushar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study
    Hamilton, Erika
    Galsky, Matthew D.
    Ochsenreither, Sebastian
    Del Conte, Gianluca
    Martin, Miguel
    De Miguel, Maria Jose
    Yu, Evan Y.
    Williams, Anja
    Gion, Maria
    Tan, Antoinette R.
    Agrawal, Laila
    Rutten, Annemie
    Machiels, Jean-Pascal
    Cresta, Sara
    Debruyne, Philip R.
    Hennequin, Audrey
    Moreno, Victor
    Minchom, Anna
    Valdes-Albini, Frances
    Petrylak, Daniel
    Li, Li
    Tsuchihashi, Zenta
    Suto, Fumitaka
    Cheng, Fu-Chih
    Kandil, Maha
    Barrios, Daniel
    Hurvitz, Sara
    CLINICAL CANCER RESEARCH, 2024, 30 (24) : 5548 - 5558
  • [38] Toward customized trastuzumab in HER-2/neu-overexpressing non-small-cell lung cancers
    Rosell, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) : 1171 - 1173
  • [39] Consensus for HER2 alterations testing in non-small-cell lung cancer
    Ren, S.
    Wang, J.
    Ying, J.
    Mitsudomi, T.
    Lee, D. H.
    Wang, Z.
    Chu, Q.
    Mack, P. C.
    Cheng, Y.
    Duan, J.
    Fan, Y.
    Han, B.
    Hui, Z.
    Liu, A.
    Liu, J.
    Lu, Y.
    Ma, Z.
    Shi, M.
    Shu, Y.
    Song, Q.
    Song, X.
    Song, Y.
    Wang, C.
    Wang, X.
    Wang, Z.
    Xu, Y.
    Yao, Y.
    Zhang, L.
    Zhao, M.
    Zhu, B.
    Zhang, J.
    Zhou, C.
    Hirsch, F. R.
    ESMO OPEN, 2022, 7 (01)
  • [40] Pilot evaluation of a HER2 testing in non-small-cell lung cancer
    Hotta, Katsuyuki
    Yanai, Hiroyuki
    Ohashi, Kadoaki
    Ninomiya, Kiichiro
    Nakashima, Hiromi
    Kayatani, Hiroe
    Takata, Minoru
    Kiura, Katsuyuki
    JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (06) : 353 - 357
12345